Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
3.040
+0.030 (1.00%)
Nov 4, 2024, 4:00 PM EST - Market closed
Trevi Therapeutics Employees
Trevi Therapeutics had 25 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
25
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,550,920
Market Cap
220.68M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Lifecore Biomedical | 524 |
Utah Medical Products | 190 |
Mersana Therapeutics | 123 |
Semler Scientific | 92 |
Solid Biosciences | 88 |
Eton Pharmaceuticals | 30 |
Benitec Biopharma | 16 |
TRVI News
- 5 days ago - Trevi Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on November 6, 2024 - PRNewsWire
- 14 days ago - Trevi Therapeutics Completes Enrollment for Phase 2a RIVER Trial in Refractory Chronic Cough - PRNewsWire
- 20 days ago - Trevi Therapeutics to Participate in Upcoming Commercial and Investor Conferences - PRNewsWire
- 4 weeks ago - Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program - PRNewsWire
- 5 weeks ago - Trevi Therapeutics Announces Appointment of James V. Cassella, Ph.D. - PRNewsWire
- 5 weeks ago - Trevi Therapeutics Announces Additional Analyses of Cough Relief Time from Ph2a CANAL Trial Accepted for Oral Presentation at CHEST 2024 - PRNewsWire
- 2 months ago - Trevi Therapeutics Announces Oral Presentation on Data from Ph2a CANAL Trial at the European Respiratory Society Congress 2024 - PRNewsWire
- 2 months ago - Trevi Therapeutics to Participate in September Investor and Medical Conferences - PRNewsWire